---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-004977"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2025-04-16T23:59:59+00:00"
generated_at: "2026-05-23T13:19:57.892995+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Glucotrack joins EU-funded FORGETDIABETES bionic pancreas initiative

## Summary
- Glucotrack's CBGM will provide real-time glucose data for automated insulin delivery system.
- FORGETDIABETES is funded by EU Horizon 2020 (€75B program) to develop a long-term bionic pancreas.
- Partnership with University of Padova and other European research institutions.
- Glucotrack CBGM is long-term implantable (3-year sensor), no on-body wearable.

## SEC filing metadata
- accession: 0001641172-25-004977
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2025-04-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000164117225004977/0001641172-25-004977-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000164117225004977/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-004977
- JSON: https://secwatch.observer/filing/0001641172-25-004977.json
- Plain text: https://secwatch.observer/filing/0001641172-25-004977.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.